A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MZL / marginal zone lymphoma

[Related PubMed/MEDLINE]
Total Number of Papers: 296
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MZL  (>> Co-occurring Abbreviation)
Long Form:   marginal zone lymphoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A rare face of follicular lymphoma: reverse variant of follicular lymphoma. FISH, NLPHL, PTGC, RVFL
2020 Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients. ORR
2020 Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature. DLBCL, IgH, SS
2020 Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models. Bcl-2, MCL, MCL1, PI3K
2020 Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews. DETs, FL, HRQoL, ICER, NHL, QALY, R-CVP
2020 Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases. EBV
2020 Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder. ---
2020 Extra-Nodal Marginal Zone Lymphoma (MZL) of MALT CD20+ of the Ocular Adnexa: Case Report. ---
2020 First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4. CR, CR/PR, EFS, FL, FLIPI, iNHLs, LPL, MALT, OS, PFS, PR, RM, SLL, WM
10  2020 High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. BL, DLBCL, HTS, OA, PT
11  2020 Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database. B-NHL, CLL/SLL, DLBCL, FL, MCL, NHL, SPM, WM
12  2020 Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog. DLBCL, FL
13  2020 Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma. FCL, PCBCLs
14  2020 Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium: case report. CNS, MBL
15  2020 Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study. CI, CLL, DLBCL, FL, MR, NHL, OR
16  2020 Marginal zone lymphoma in a dog. ---
17  2020 Persistent Extranodal Marginal Zone Lymphoma (MZL) in the Capsule of a Re-explanted Silicone Prosthesis Following Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). BIA-ALCL
18  2020 PET/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma. PET/CT
19  2020 Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma. ---
20  2020 Primary gastric lymphoma: A report of 16 pediatric cases treated at a single institute and review of the literature. H. pylori, MALT, NHLs, PGL
21  2020 Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma. FL, LG-NHL, WM
22  2020 Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era. 5-PS, FDG, PET/CT, PFS
23  2020 Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients. CR, CRR, ENLG, GIT, LC, NHL, ORR, OS, PFS, RT
24  2020 Single-fraction low-energy electronic brachytherapy for conjunctival lymphoma. MALT
25  2019 An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma. CI, FL, LPL/WM, MCL, PFS, Syk
26  2019 Burden of illness of follicular lymphoma and marginal zone lymphoma. FL, NHL
27  2019 CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. B-LPD, LPL, WM
28  2019 Composite breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and extra-nodal marginal zone lymphoma (MZL) in the capsule of a silicone breast implant. BIA-ALCL
29  2019 Contemporary management of nodal and primary splenic marginal zone lymphoma. ---
30  2019 Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma. CLL, DLBCL, FL, HCL, MCL, SDRPBL
31  2019 FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma. CT, DS, HR, OS, PFS, VAS
32  2019 Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma. MCL
33  2019 Genetically Determined Height and Risk of Non-hodgkin Lymphoma. CI, CLL, DLBCL, FL, GWAS, NHL, OR
34  2019 Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma. MCL
35  2019 Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial. AE, CR, PR, ORR, PFS
36  2019 Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization. Bcl, DLBCL, FL, lncRNAs
37  2019 Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma. FL, iNHL, OS, PCR, PFS, SLL
38  2019 Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network. AT, DAAs, DLBCL, HCV, NHL, OS, REL
39  2019 Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma. LPL
40  2019 Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab. APLA
41  2019 Marginal Zone Lymphoma: State-of-the-Art Treatment. FL, iNHL, PI3K
42  2019 Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study. CISL, CR, OS, PFS, PR, SD
43  2019 Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma. B2M, I/ICT
44  2019 Response to Interferon-Free Direct Antivirals (DAAS) Treatment in Hcv-Related Subcutaneous Marginal Zone B-Cell Lymphoma with Lipoma-Like Presentation: Report of Two Cases. DAAS, DAAs, NHL, SVR
45  2019 Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. CI, DLBCL, NHL, SIR
46  2019 Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ? BL, DLBCL, FL, MCL, NHL, PTCL, SEER, SLL
47  2019 The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network. ABC, DLBCL
48  2019 Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort. CLL, WHO
49  2018 A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CLL, CNS, SLL
50  2018 Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment. MCL, PARR
51  2018 Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. EMZL, NMZL
52  2018 Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma. cTfh, cTfh1, FL, Tfh, TME
53  2018 Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. DLBCL, HCV
54  2018 Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas. DLBCL, FL, GC, HGAL, LMO2, MEF2B
55  2018 Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL). CMR, PET-CT, PFS
56  2018 Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders. B-CLPD, CLL, FISH, OS
57  2018 Effective management strategies for patients with marginal zone lymphoma. ---
58  2018 Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry. CLL, MCL
59  2018 Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings. EBV
60  2018 High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO. ASCT, EFS, NMZL, OS, SMZL
61  2018 HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. CLL/SLL, DLBCL, FL, GWAS, HLA, NHL
62  2018 Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy. FDA
63  2018 Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms. MCL, MFI
64  2018 Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution. CR, HGT, IPI, OS, SHR
65  2018 [Research Progress on Diagnosis and Treatment of B Cell Chronic Lymphoproliferative Disease--Review]. B-CLPD, B-PLL, CLL, FL, HCL, LPL/WM, MCL, WHO
66  2017 A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy. FL, LR-CD, NHL, OS, WM
67  2017 Chronic amastigote-negative cutaneous leishmaniasis: A clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentations. CL, PCR
68  2017 Diffuse Subcutaneous Fat Involvement in a Marginal Zone Lymphoma. ---
69  2017 Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88L265P Mutation. ---
70  2017 Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders. B-LPDs, HCL, HCL-v, LPL
71  2017 Hepatitis C virus - Associated marginal zone lymphoma. DLBCL, HCV
72  2017 Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma. GCB, IRTA1
73  2017 Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. ---
74  2017 Marginal zone lymphoma in elderly and geriatric patients. ---
75  2017 Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial. IPI, PFS, PLR, R-CVP, R-CVP
76  2017 PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma. LPL
77  2017 Primary Breast Lymphoma in the United States: 1975-2013. ALCL, APC, CI, DLBCL, PBL, SEER
78  2017 Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities. CNS, MRI, PET
79  2017 Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma. BCR, CI, ORR
80  2017 The role of stem-cell transplantation in the treatment of marginal zone lymphoma. ASCT
81  2017 Transformation of marginal zone lymphoma (and association with other lymphomas). HT, MALT, NHL
82  2017 Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom's Macroglobulinemia. LPL, MYD88, NCCN, WM
83  2016 A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Ox-P
84  2016 Amyloid deposition in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: A clinicopathologic study of 5 cases. MALT
85  2016 CD180 expression in B-cell lymphomas: A multicenter GEIL study. HCL, MdFI
86  2016 Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS"). DLBCL, NHL, SEER, TCL
87  2016 Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. CLL/SLL, FL, HCL, LPL, MCL, NGS, SBCLs, SMZL
88  2016 In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. DLBCL, HCV, NHL, NS3
89  2016 Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas. DLBCL, FL, GEO, MCL
90  2016 MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation. MALT, NHLs
91  2016 Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. BIRC3, CT, DLBCL, DLBCL-IF, PET
92  2016 Minimal change disease: an unusual presentation of marginal zone MALT lymphoma. MALT, MCD, R-Benda
93  2016 Primary Marginal Zone Lymphoma in the Posterior Mediastinum with Pleural Involvement. ---
94  2016 Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. CI, MR, ORR, RESORT, RR, SLL, TTTF
95  2016 The genetic landscape of dural marginal zone lymphomas. LOH
96  2016 [A Case of Primary Dural Lymphoma of Jugular Tubercle Mimicking Lower Clival Meningioma]. CT, MRI, PCNSL, PDL
97  2016 [Marginal zone lymphoma with monoclonal immunoglobulin: three cases report and literatures review]. CR, MALTL, mc Ig, ORR
98  2015 A genome-wide association study of marginal zone lymphoma shows association to the HLA region. ---
99  2015 Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. AT, B-NHL, DLBCL, HCV, OS
100  2015 EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma. cHL, LDCHL